Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease
Alzheimer’s disease (AD) is one of the most common causes of dementia. Although significant breakthroughs have been made in understanding the progression and pathogenesis of AD, it remains a worldwide problem and a significant public health burden. Thus, more efficient diagnostic and therapeutic str...
Main Authors: | Yuqing Liu, Xin Cheng, Hongli Li, Shan Hui, Zheyu Zhang, Yang Xiao, Weijun Peng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-06-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.908076/full |
Similar Items
-
Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an aβ25-35-induced rat model of Alzheimer’s disease
by: Hongli Li, et al.
Published: (2022-10-01) -
Emerging role of non-coding RNAs in neuroinflammation mediated by microglia and astrocytes
by: Ruicheng Yang, et al.
Published: (2023-07-01) -
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
by: Nour F. Al-Ghraiybah, et al.
Published: (2022-09-01) -
CircRNAs in Alzheimer's disease: What are the prospects?
by: Ozal Beylerli, et al.
Published: (2024-03-01) -
Targeting neuroinflammation in Alzheimer’s disease: from mechanisms to clinical applications
by: Zi-Zhen Si, et al.
Published: (2023-01-01)